Lung cancer is one of the many types of cancer that strike the world’s population every year, with the symptoms only showing as the disease progresses. There is a simple test that can determine whether someone may be suffering from this disease.
Express reports that a person who may be suffering from lung cancer may also be suffering from paraneoplastic syndromes. This kind of disorder is usually brought on by small-cell lung cancer cells and it can attack other parts of the nervous system, not just the lungs. The American Cancer Society notes that syndromes like the Lambert-Eaton syndrome as an example. This syndrome results in the muscles around the hips to weaken.
An indicator of this syndrome can be seen through a standing and sitting test. If a person has trouble getting up from a sitting position, then it is possible they would be suffering from Lambert-Eaton syndrome. Later stages of this disorder will also see the shoulder muscles weaken as well. This would result in the possibility of a person suffering from lung cancer as the root of it all.
Further noting, other changes brought on by small cell lung cancer are in behavior, vision, and sensations among other kinds of nervous system disorders.
There are many causes of lung cancer, and the most common cause is excessive smoking and air pollution. Smokers make up a big portion of patients who suffer from lung cancer. Non-smokers can also unfortunately suffer from this disease, this is mostly attributed to inhaling secondhand smoke from smoking areas, as well as air pollution and exposure to chemicals like asbestos. Previous respiratory diseases may also play a part in how big a risk would a person have to lung cancer.
Prevention is better than the cure, and it is important to keep the lungs as healthy as the heart and the rest of the body. Some ways to maintain healthy lungs is through simple breathing exercises, drinking plenty of water, paying attention to one’s posture, engaging in physical activity, and even doing something as simple as laughing can help keep the lungs healthy.


AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook
Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss
France Battles Mediterranean Wildfires as Heatwave Fuels Fire Risk
U.S. Issues Cuba Health Alert as Illnesses Rise
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
US-Backed Pediatric HIV Treatment Drops After Foreign Aid Changes, Study Finds
Trump Signs Order to Cut Routine Childhood Vaccines
Novartis M&A Strategy Faces Investor Scrutiny After Drug Setbacks
GLP-1 Weight-Loss Drug Use Surges Among U.S. Children
Novo Nordisk Strikes €1.17 Billion Nanexa Drug Delivery Deal
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
FDA Approves Mirum’s Atebrioz for Rare Bone Disorder FOP 



